Skip to content

Registry of Antiepileptic Drugs and Pregnancy

Registry of Antiepileptic Drugs and Pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077393
Enrollment
Unknown
Registered
2023-11-07
Start date
2023-11-10
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Women with epilepsy:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Patients with epilepsy, meeting the 2014 International ILAE epilepsy diagnostic criteria and 2017 ILAE epilepsy classification criteria; 2.Women; 3.Pregnant patients before the 16th week of pregnancy; 4.Patients exposed to antiepileptic drugs at the time of conception 5.Patients willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant patients after the 16th week of pregnancy; 2.Patients who do not live locally for a long time or are otherwise unable to follow up; 3.Patients unable to conceive due to hysterectomy or adnexectomy; 4.Patients without autonomous ability, severe mental disorder or other reasons can not cooperate with the study.

Design outcomes

Primary

MeasureTime frame
Use of anti-seizure medications;Seizure frequency;Production inspection;Newborn health evaluation;

Secondary

MeasureTime frame
Pregnancy complication;Delivery methods;

Countries

China

Contacts

Public ContactLei Chen

West China Hospital, Sichuan University

leilei_25@126.com+86 189 8060 5819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026